XML 96 R85.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings (Loss) Per Common Share - Computation of Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Earnings Per Share [Abstract]        
Income (loss) from continuing operations $ (9,107) $ (202,013) $ (20,297) $ (280,500)
Income (loss) from discontinued operations, net of tax [1] 0 (1,508) 1,383 (1,773)
Net income (loss) (9,107) (203,521) (18,914) (282,273)
Less:        
Net loss attributable to non-controlling interests 0 0 0 0
Net loss attributable to common shareholders of Evolent Health, Inc. (9,107) (203,521) (18,914) (282,273)
Net loss attributable to common shareholders of Evolent Health, Inc. $ (9,107) $ (203,521) $ (18,914) $ (282,273)
Weighted-average common shares outstanding - basic (in shares) 85,448 85,349 85,056 84,977
Weighted-average common shares outstanding - diluted (in shares) 85,448 85,349 85,056 84,977
Loss per common share, Basic and diluted        
Continuing operations, basic (in dollars per share) $ (0.11) $ (2.37) $ (0.24) $ (3.30)
Continuing operations, diluted (in dollars per share) (0.11) (2.37) (0.24) (3.30)
Discontinued operations, diluted (in dollars per share) 0 (0.01) 0.02 (0.02)
Discontinued operations, basic (in dollars per share) 0 (0.01) 0.02 (0.02)
Diluted loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) (0.11) (2.38) (0.22) (3.32)
Basic loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) $ (0.11) $ (2.38) $ (0.22) $ (3.32)
[1] Includes $1.9 million gain on disposal of discontinued operations for the six months ended June 30, 2021